Publicou 6 edições por ano
ISSN Imprimir: 1040-8401
ISSN On-line: 2162-6472
Indexed in
IL-21 Is an Immune Activator That also Mediates Suppression via IL-10
RESUMO
Interleukin-21 (IL-21) is a pleiotropic type I cytokine that is produced predominantly by CD4+ T cells and natural killer T (NKT) cells. Although IL-21 production is relatively restricted to these two populations of immune cells, its targets are numerous, including multiple lympho-hematopoietic as well as non-hematopoietic lineages. The effects of IL-21 are specific not only to the target cell type, but also depend on the developmental stage of the target cell as well as the available co-stimulatory signals. Accordingly, IL-21 functions not only as a strong inducer of differentiation and proliferation but also as a pro-apoptotic factor. Although most of the effects of IL-21 are immunostimulatory, it has become clear that one of the cytokines that is potently induced by IL-21 in a number of lymphoid lineages is interleukin-10 (IL-10), one of the most immunosuppressive cytokines. The seemingly contradictory actions of IL-21 and IL-10 and the consequences of their co-expression are currently being explored in numerous infectious models, autoimmune diseases, and tumor responses. This review seeks to critically evaluate the evidence concerning the regulation of IL-10 by IL-21 in a number of lineage subsets as well as to discuss the potential positive versus deleterious roles that this co-expression may play in a range of disease models.
-
Jin Jun-O, Han Xiaozhe, Yu Qing, Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation, Journal of Autoimmunity, 40, 2013. Crossref
-
Oppenheim Joost J., Cytokines, their Receptors and Signals, in The Autoimmune Diseases, 2014. Crossref
-
Yadav Praveen K., Chen Chi, Liu Zhanju, Potential Role of NK Cells in the Pathogenesis of Inflammatory Bowel Disease, Journal of Biomedicine and Biotechnology, 2011, 2011. Crossref
-
Meazza Raffaella, Azzarone Bruno, Orengo Anna Maria, Ferrini Silvano, Role of Common-Gamma Chain Cytokines in NK Cell Development and Function: Perspectives for Immunotherapy, Journal of Biomedicine and Biotechnology, 2011, 2011. Crossref
-
Ahmadi Maryam, Bryson Christine J., Cloake Edward A., Welch Katie, Filipe Vasco, Romeijn Stefan, Hawe Andrea, Jiskoot Wim, Baker Matthew P., Fogg Mark H., Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics, Pharmaceutical Research, 32, 4, 2015. Crossref
-
Liu Wei, Dienz Oliver, Roberts Brian, Moussawi Mohamad, Rincon Mercedes, Huber Sally A., IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis, Experimental and Molecular Pathology, 92, 3, 2012. Crossref
-
Salehi Zahra, Doosti Rozita, Beheshti Masoumeh, Janzamin Ehsan, Sahraian Mohammad Ali, Izad Maryam, Infante-Duarte Carmen, Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns, PLOS ONE, 11, 7, 2016. Crossref
-
Spolski Rosanne, Leonard Warren J., Interleukin-21, in Cancer Therapeutic Targets, 2017. Crossref
-
Monjazeb Arta M., Tietze Julia K., Grossenbacher Steven K., Hsiao Hui-Hua, Zamora Anthony E., Mirsoian Annie, Koehn Brent, Blazar Bruce R., Weiss Jonathan M., Wiltrout Robert H., Sckisel Gail D., Murphy William J., Lapteva Natalia, Bystander Activation and Anti-Tumor Effects of CD8+ T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+ T Cell Help, PLoS ONE, 9, 8, 2014. Crossref
-
Labanieh Louai, Majzner Robbie G., Mackall Crystal L., Programming CAR-T cells to kill cancer, Nature Biomedical Engineering, 2, 6, 2018. Crossref
-
Freitas do Rosário Ana Paula, Lamb Tracey, Spence Philip, Stephens Robin, Lang Agathe, Roers Axel, Muller Werner, O’Garra Anne, Langhorne Jean, IL-27 Promotes IL-10 Production by Effector Th1 CD4+T Cells: A Critical Mechanism for Protection from Severe Immunopathology during Malaria Infection, The Journal of Immunology, 188, 3, 2012. Crossref
-
Spolski Rosanne, Leonard Warren J., Interleukin 21, in Cancer Therapeutic Targets, 2016. Crossref
-
McPhee Caroline G., Bubier Jason A., Sproule Thomas J., Park Giljun, Steinbuck Martin P., Schott William H., Christianson Gregory J., Morse Herbert C., Roopenian Derry C., IL-21 Is a Double-Edged Sword in the Systemic Lupus Erythematosus–like Disease of BXSB.Yaa Mice, The Journal of Immunology, 191, 9, 2013. Crossref
-
Solaymani-Mohammadi Shahram, Eckmann Lars, Singer Steven M., Interleukin (IL)-21 in Inflammation and Immunity During Parasitic Diseases, Frontiers in Cellular and Infection Microbiology, 9, 2019. Crossref
-
Oppenheim Joost J., Cytokines, Their Receptors and Signals, in The Autoimmune Diseases, 2020. Crossref
-
Zhao Yi, Zhang Zhiyu, Lei Wenbin, Wei Yi, Ma Renqiang, Wen Yihui, Wei Fanqin, Fan Jun, Xu Yang, Chen Lin, Lyu Kexing, Lin Hanqing, Wen Weiping, Sun Wei, IL-21 Is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer, Frontiers in Oncology, 11, 2021. Crossref
-
Metcalf Talibah U., Baxter Victoria K., Nilaratanakul Voraphoj, Griffin Diane E., Recruitment and Retention of B Cells in the Central Nervous System in Response to Alphavirus Encephalomyelitis, Journal of Virology, 87, 5, 2013. Crossref
-
Liu Yilin, Wang Gang, Chai Dafei, Dang Yuanyuan, Zheng Junnian, Li Huizhong, iNKT: A new avenue for CAR-based cancer immunotherapy, Translational Oncology, 17, 2022. Crossref
-
Lindner Stefanie, Dahlke Karen, Sontheimer Kai, Hagn Magdalena, Kaltenmeier Christof, Barth Thomas F.E., Beyer Thamara, Reister Frank, Fabricius Dorit, Lotfi Ramin, Lunov Oleg, Nienhaus G. Ulrich, Simmet Thomas, Kreienberg Rolf, Möller Peter, Schrezenmeier Hubert, Jahrsdörfer Bernd, Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells, Cancer Research, 73, 8, 2013. Crossref
-
Džopalić Tanja, Tomić Sergej, Bekić Marina, Vučević Dragana, Mihajlović Dušan, Eraković Mile, Čolić Miodrag, Ex vivo study of IL‐6 expression and function in immune cell subsets from human periapical lesions , International Endodontic Journal, 55, 5, 2022. Crossref